Nantahala Capital Management - Q4 2023 holdings

 Value Shares↓ Weighting
ExitTC BIOPHARM HOLDINGS PLC*w exp 02/08/202$0-235,294
-100.0%
0.00%
ExitNOGIN INC*w exp 08/26/202$0-330,000
-100.0%
-0.00%
ExitNOGIN INC$0-56,425
-100.0%
-0.00%
CBIO ExitCATALYST BIOSCIENCES INC$0-67,800
-100.0%
-0.00%
CUE ExitCUE BIOPHARMA INC$0-26,760
-100.0%
-0.01%
ExitGUARDFORCE AI CO LTD*w exp 10/01/202$0-154,205
-100.0%
-0.01%
GAIA ExitGAIA INC NEWcl a$0-23,144
-100.0%
-0.01%
ExitKINTARA THERAPEUTICS INC$0-22,619
-100.0%
-0.01%
ExitAKUMIN INC$0-979,196
-100.0%
-0.01%
RFL ExitRAFAEL HLDGS INC$0-72,678
-100.0%
-0.01%
BMTX ExitBM TECHNOLOGIES INC$0-79,212
-100.0%
-0.01%
ExitLUCID DIAGNOSTICS INC$0-158,135
-100.0%
-0.02%
TACT ExitTRANSACT TECHNOLOGIES INC$0-31,108
-100.0%
-0.02%
ExitABEONA THERAPEUTICS INCcall$0-52,000
-100.0%
-0.02%
ADCT ExitADC THERAPEUTICS SA$0-257,162
-100.0%
-0.02%
XGN ExitEXAGEN INC$0-106,769
-100.0%
-0.02%
ExitELICIO THERAPEUTICS INC$0-30,000
-100.0%
-0.02%
LADR ExitLADDER CAP CORPcl a$0-27,073
-100.0%
-0.02%
KROS ExitKEROS THERAPEUTICS INCcall$0-12,300
-100.0%
-0.03%
ExitAPTOSE BIOSCIENCES INC$0-136,483
-100.0%
-0.03%
TIL ExitINSTIL BIO INC$0-1,000,000
-100.0%
-0.04%
ExitACELRX PHARMACEUTICALS INCcall$0-755,000
-100.0%
-0.04%
SRTS ExitSENSUS HEALTHCARE INC$0-185,048
-100.0%
-0.04%
REPH ExitSOCIETAL CDMO INC$0-1,250,000
-100.0%
-0.05%
ExitACELRX PHARMACEUTICALS INC$0-1,173,015
-100.0%
-0.06%
ACER ExitACER THERAPEUTICS INC$0-918,349
-100.0%
-0.06%
SGRP ExitSPAR GROUP INC$0-879,189
-100.0%
-0.07%
TBBK ExitBANCORP INC DEL$0-24,896
-100.0%
-0.07%
ExitJOURNEY MED CORP$0-348,663
-100.0%
-0.08%
QURE ExitUNIQURE NVcall$0-147,700
-100.0%
-0.08%
RZLT ExitREZOLUTE INC$0-769,606
-100.0%
-0.09%
NMTC ExitNEUROONE MED TECHNOLOGIES CO$0-1,250,000
-100.0%
-0.10%
ExitNEOLEUKIN THERAPEUTICS INC$0-299,999
-100.0%
-0.10%
RMBL ExitRUMBLEON INCcall$0-200,000
-100.0%
-0.10%
TGTX ExitTG THERAPEUTICS INC$0-150,000
-100.0%
-0.11%
AVTE ExitAEROVATE THERAPEUTICS INC$0-95,000
-100.0%
-0.11%
AAN ExitTHE AARONS COMPANY INC$0-138,572
-100.0%
-0.12%
EHTH ExitEHEALTH INCcall$0-203,100
-100.0%
-0.13%
ANEB ExitANEBULO PHARMACEUTICALS INC$0-511,073
-100.0%
-0.13%
SRL ExitSCULLY ROYALTY LTD$0-298,491
-100.0%
-0.14%
ExitJASPER THERAPEUTICS INC$0-2,402,904
-100.0%
-0.14%
FBIO ExitFORTRESS BIOTECH INC$0-6,018,211
-100.0%
-0.15%
CCCC ExitC4 THERAPEUTICS INC$0-1,000,000
-100.0%
-0.16%
MAX ExitMEDIAALPHA INCcl a$0-234,372
-100.0%
-0.16%
SSKN ExitSTRATA SKIN SCIENCES INC$0-3,264,945
-100.0%
-0.17%
IMTXW ExitIMMATICS N.V*w exp 07/01/202$0-558,977
-100.0%
-0.17%
FOSL ExitFOSSIL GROUP INC$0-985,215
-100.0%
-0.17%
SELB ExitSELECTA BIOSCIENCES INC$0-2,200,000
-100.0%
-0.20%
AZYO ExitELUTIA INC$0-1,650,000
-100.0%
-0.20%
CDTX ExitCIDARA THERAPEUTICS INC$0-2,538,406
-100.0%
-0.20%
TARS ExitTARSUS PHARMACEUTICALS INC$0-135,500
-100.0%
-0.21%
NNBR ExitNN INC$0-1,353,143
-100.0%
-0.22%
RILY ExitB. RILEY FINANCIAL INC$0-62,520
-100.0%
-0.22%
PWP ExitPERELLA WEINBERG PARTNERS$0-258,273
-100.0%
-0.22%
ENVA ExitENOVA INTL INC$0-53,250
-100.0%
-0.23%
SNDX ExitSYNDAX PHARMACEUTICALS INCcall$0-200,000
-100.0%
-0.25%
ExitAYTU BIOPHARMA INC$0-1,086,812
-100.0%
-0.25%
ExitUNICYCIVE THERAPEUTICS INC$0-3,470,541
-100.0%
-0.26%
INMD ExitINMODE LTDput$0-100,000
-100.0%
-0.26%
PNT ExitPOINT BIOPHARMA GLOBAL INC$0-521,191
-100.0%
-0.30%
SNDX ExitSYNDAX PHARMACEUTICALS INC$0-240,031
-100.0%
-0.30%
ASPS ExitALTISOURCE PORTFOLIO SOLNS S$0-904,462
-100.0%
-0.31%
TELA ExitTELA BIO INC$0-456,092
-100.0%
-0.31%
EOLS ExitEVOLUS INC$0-421,220
-100.0%
-0.33%
IWM ExitISHARES TRrussell 2000 etf$0-21,878
-100.0%
-0.33%
AGS ExitPLAYAGS INC$0-594,574
-100.0%
-0.33%
ALTG ExitALTA EQUIPMENT GROUP INC$0-322,632
-100.0%
-0.33%
IDYA ExitIDEAYA BIOSCIENCES INC$0-145,860
-100.0%
-0.34%
SVRA ExitSAVARA INC$0-1,039,364
-100.0%
-0.34%
OPTN ExitOPTINOSE INC$0-3,307,942
-100.0%
-0.35%
SBTX ExitARS PHARMACEUTICALS INC$0-1,099,075
-100.0%
-0.36%
PTON ExitPELOTON INTERACTIVE INCcall$0-852,000
-100.0%
-0.37%
ExitPAR TECHNOLOGY CORPnote 2.875% 4/1$0-3,785,000
-100.0%
-0.37%
VNDA ExitVANDA PHARMACEUTICALS INC$0-1,000,000
-100.0%
-0.37%
BXMT ExitBLACKSTONE MTG TR INCput$0-200,000
-100.0%
-0.37%
XTNT ExitXTANT MED HLDGS INC$0-4,000,000
-100.0%
-0.38%
GMDA ExitGAMIDA CELL LTD$0-4,325,000
-100.0%
-0.38%
ExitDIANTHUS THERAPEUTICS INC$0-336,862
-100.0%
-0.39%
IMAX ExitIMAX CORPcall$0-250,000
-100.0%
-0.41%
GOSS ExitGOSSAMER BIO INC$0-6,089,471
-100.0%
-0.43%
KRTX ExitKARUNA THERAPEUTICS INCcall$0-30,000
-100.0%
-0.43%
ExitVENTYX BIOSCIENCES INC$0-147,623
-100.0%
-0.44%
CYTK ExitCYTOKINETICS INC$0-179,257
-100.0%
-0.45%
RH ExitRH$0-20,853
-100.0%
-0.47%
COGT ExitCOGENT BIOSCIENCES INC$0-575,000
-100.0%
-0.48%
ExitAN2 THERAPEUTICS INC$0-356,789
-100.0%
-0.49%
NSPR ExitINSPIREMD INC$0-1,768,050
-100.0%
-0.49%
EHTH ExitEHEALTH INC$0-800,000
-100.0%
-0.51%
ExitRESERVOIR MEDIA INC$0-986,328
-100.0%
-0.51%
RDI ExitREADING INTL INCcl a$0-2,876,040
-100.0%
-0.52%
DYN ExitDYNE THERAPEUTICS INC$0-683,164
-100.0%
-0.52%
DXPE ExitDXP ENTERPRISES INC$0-179,987
-100.0%
-0.54%
ExitAURA BIOSCIENCES INC$0-743,892
-100.0%
-0.57%
ILPT ExitINDUSTRIAL LOGISTICS PPTYS T$0-2,357,284
-100.0%
-0.58%
ZM ExitZOOM VIDEO COMMUNICATIONS INcall$0-100,000
-100.0%
-0.60%
ExitAMYLYX PHARMACEUTICALS INC$0-407,205
-100.0%
-0.64%
ExitDARIOHEALTH CORP$0-2,414,192
-100.0%
-0.68%
DHX ExitDHI GROUP INC$0-2,698,201
-100.0%
-0.70%
TALS ExitTALARIS THERAPEUTICS INC$0-2,953,129
-100.0%
-0.71%
MLHR ExitMILLERKNOLL INC$0-340,228
-100.0%
-0.71%
HLF ExitHERBALIFE LTDcall$0-600,000
-100.0%
-0.72%
NDLS ExitNOODLES & CO$0-3,495,827
-100.0%
-0.74%
AMRX ExitAMNEAL PHARMACEUTICALS INC$0-2,212,757
-100.0%
-0.80%
CDXS ExitCODEXIS INC$0-5,069,443
-100.0%
-0.82%
ExitABEONA THERAPEUTICS INC$0-2,297,794
-100.0%
-0.83%
RMBL ExitRUMBLEON INC$0-1,605,392
-100.0%
-0.84%
PAYO ExitPAYONEER GLOBAL INC$0-1,612,862
-100.0%
-0.84%
HGV ExitHILTON GRAND VACATIONS INCcall$0-250,000
-100.0%
-0.87%
KROS ExitKEROS THERAPEUTICS INC$0-328,781
-100.0%
-0.90%
RH ExitRHcall$0-40,000
-100.0%
-0.90%
RMR ExitRMR GROUP INCcl a$0-432,033
-100.0%
-0.90%
KMPH ExitZEVRA THERAPEUTICS INC$0-2,308,216
-100.0%
-0.95%
GDEN ExitGOLDEN ENTMT INC$0-332,056
-100.0%
-0.97%
ExitSOLENO THERAPEUTICS INC$0-392,404
-100.0%
-0.99%
NPCE ExitNEUROPACE INC$0-1,219,915
-100.0%
-1.01%
ASRT ExitASSERTIO HOLDINGS INC$0-4,670,000
-100.0%
-1.02%
VMD ExitVIEMED HEALTHCARE INC$0-2,032,170
-100.0%
-1.17%
LYRA ExitLYRA THERAPEUTICS INC$0-4,050,218
-100.0%
-1.35%
PTON ExitPELOTON INTERACTIVE INC$0-3,554,606
-100.0%
-1.53%
BVS ExitBIOVENTUS INC$0-6,018,532
-100.0%
-1.70%
QURE ExitUNIQURE NV$0-3,023,799
-100.0%
-1.73%
HGV ExitHILTON GRAND VACATIONS INC$0-504,242
-100.0%
-1.75%
CRMT ExitAMERICAS CAR-MART INC$0-230,953
-100.0%
-1.80%
IMTX ExitIMMATICS N.V$0-1,920,636
-100.0%
-1.90%
KRE ExitSPDR SER TRput$0-600,000
-100.0%
-2.14%
RDVT ExitRED VIOLET INC$0-1,261,896
-100.0%
-2.16%
LXFR ExitLUXFER HLDGS PLC$0-2,121,162
-100.0%
-2.36%
ESTA ExitESTABLISHMENT LABS HLDGS INCcall$0-579,000
-100.0%
-2.43%
IMAX ExitIMAX CORP$0-2,606,884
-100.0%
-4.30%
CASH ExitPATHWARD FINANCIAL INC$0-1,234,526
-100.0%
-4.86%
XBI ExitSPDR SER TRput$0-950,000
-100.0%
-5.93%
ESTA ExitESTABLISHMENT LABS HLDGS INC$0-1,887,617
-100.0%
-7.91%
IWM ExitISHARES TRput$0-1,100,000
-100.0%
-16.61%
About Nantahala Capital Management

Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.

Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.

Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.

Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR42Q3 202327.2%
CODEXIS INC42Q3 20233.9%
PATHWARD FINANCIAL INC35Q3 20236.3%
SCIENTIFIC GAMES CORP34Q3 20225.3%
DOVER MOTORSPORTS INC34Q3 20210.5%
GOLDEN ENTMT INC33Q3 20232.1%
QAD INC32Q3 20212.6%
SCIENTIFIC GAMES CORP31Q4 20217.7%
DOLBY LABORATORIES INC31Q4 20205.6%
LINCOLN EDL SVCS CORP31Q4 20210.7%

View Nantahala Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Nantahala Capital Management Q4 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AYTU BIOPHARMA, INCJune 16, 20231,086,81219.7%
Acer Therapeutics Inc.February 14, 20231,226,1917.5%
Aeglea BioTherapeutics, Inc.February 14, 20234,611,3027.5%
AKUMIN INC.February 14, 20232,206,9602.5%
ALTA EQUIPMENT GROUP INC.February 14, 20231,188,9853.7%
Apollo Endosurgery, Inc.February 14, 20234,056,6279.9%
Autolus Therapeutics plcFebruary 14, 20237,782,0184.7%
Bioventus Inc.February 14, 20233,168,5745.1%
CATALYST BIOSCIENCES, INC.February 14, 2023438,0551.4%
Drive Shack Inc.February 14, 20236,500,0007.0%

View Nantahala Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-21
42024-03-15
SC 13G2024-03-11
13F-HR/A2024-02-15
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Nantahala Capital Management's complete filings history.

Compare quarters

Export Nantahala Capital Management's holdings